Induction of Immortal-like CAR-T Cells by Defined Factors
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2024-03-08
相关数据集
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CAR
Chimeric antigen receptor (CAR) T cells targeting CD19 are highly effective against B-lineage malignancies. However, about half of patients either fail to achieve complete remission (in the case of ly
NIAID Data Ecosystem70
Application of iGUIDE to identify potential off-target cleavage caused by Cas9/PD1 sgRNA
We successfully develop a two-in-one approach to generate non-viral genome specific targeted CAR T cells through CRISPRCas9. In the adoptive therapy for relapsedrefractory aggressive B-cell non-Hodgki
NIAID Data Ecosystem40
BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma. BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma
Glioblastoma (GBM) is the deadliest brain malignancy without effective treatments. Here, we report that epidermal growth factor receptor-targeted chimeric antigen receptor T cells (EGFR CAR-T) are eff
NIAID Data Ecosystem30
CAR-T Therapy Market
Global CAR-T Therapy comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential ma
IMR REPORTS40
Supplementary Data S2 from Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR
List of gene names and FPKM values from bulk RNA-seq on T cells harvested from tumor-bearing mice (Fig. 4A-D, F and Supplementary Fig. S7).
NIAID Data Ecosystem40
